Change - Announcement of Cessation::Resignation of Executive Director and Chief Executive Officer
Issuer & Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Resignation of Executive Director and Chief Executive Officer
Submitted By (Co./ Ind. Name)
Yee Pinh Jeremy
Non-Executive Non-Independent Chairman
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by Biolidics Limited (the "Company") and has been reviewed by the Company's sponsor, United Overseas Bank Limited (the "Sponsor"), for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Mr Chia Beng Kwan, Senior Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898.
Name Of Person
Lew Kwang Ping
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Pursuit of other interest.
The Sponsor, after interviewing Mr. Lew Kwang Ping, is satisfied that, save as disclosed in this announcement, there are no material reasons for the cessation of Mr. Lew Kwang Ping as Executive Director and Chief Executive Officer of the Company.
Mr. Lew Kwang Ping is currently working with the Board to help the Company transition to a new leadership and in the meantime the management and operations of the Company will continue under the helm of the Board and senior management.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chief Executive Officer
Role and responsibilities
Mr. Lew Kwang Ping is responsible for the overall management, operations, strategic planning and business development of the Company.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Past (for the last 5 years)